These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8137548)

  • 1. Immunosuppressive activity of bromocriptine on human T lymphocyte function in vitro.
    Morikawa K; Oseko F; Morikawa S
    Clin Exp Immunol; 1994 Mar; 95(3):514-8. PubMed ID: 8137548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive property of bromocriptine on human B lymphocyte function in vitro.
    Morkawa K; Oseko F; Morikawa S
    Clin Exp Immunol; 1993 Aug; 93(2):200-5. PubMed ID: 7688676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell dysregulation in patients with hyperprolactinemia: effect of bromocriptine treatment.
    Vidaller A; Llorente L; Larrea F; Mendez JP; Alcocer-Varela J; Alarcon-Segovia D
    Clin Immunol Immunopathol; 1986 Mar; 38(3):337-43. PubMed ID: 2935343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin and prolactin secretagogues reverse immunosuppression in mice treated with cysteamine, glucocorticoids, or cyclosporin-A.
    Bernton E; Bryant H; Holaday J; Dave J
    Brain Behav Immun; 1992 Dec; 6(4):394-408. PubMed ID: 1336994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bromocriptine on insulin, growth hormone and prolactin responses to arginine in obesity.
    Maccario M; Grottoli S; Procopio M; Oleandri SE; Barberis A; Ciccarelli E; Camanni F; Ghigo E
    J Endocrinol Invest; 1996 Apr; 19(4):219-23. PubMed ID: 8862501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of PPARgamma enhances in vitro the immunosuppressive effect of cyclosporine on T lymphocytes.
    Rampino T; Ranghino A; Guidetti C; Gregorini M; Soccio G; Marasà M; Libetta C; Guida G; De Amici M; Dal Canton A
    Transpl Immunol; 2007 Jul; 18(1):32-6. PubMed ID: 17584600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of bromocriptine and dopamine on pituitary hormone secretion in women].
    Masaoka K; Hosoya N; Mori T; Watanabe H; Ohkura T; Kumasaka T
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Dec; 34(12):2155-62. PubMed ID: 6818310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associated effects of bromocriptine on neoplastic progression of mouse mammary preneoplastic hyperplastic alveolar nodule line C4 and on hyperplastic alveolar nodule-infiltrating and splenic lymphocyte function.
    Tsai SJ; Loeffler DA; Heppner GH
    Cancer Res; 1992 Apr; 52(8):2209-15. PubMed ID: 1559224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation.
    Sawada S; Suzuki G; Kawase Y; Takaku F
    J Immunol; 1987 Sep; 139(6):1797-803. PubMed ID: 2442255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of anti-rheumatic drugs on in vitro mitogenic stimulation of peripheral blood mononuclear cells.
    Dijkmans BA; de Vries E; de Vreede TM; Cats A
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):253-8. PubMed ID: 3363640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive activity of fosfomycin on human T-lymphocyte function in vitro.
    Morikawa K; Oseko F; Morikawa S; Sawada M
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2684-7. PubMed ID: 7509146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromocriptine treatment of microprolactinomas: evidence of stable prolactin decrease after drug withdrawal.
    Moriondo P; Travaglini P; Nissim M; Conti A; Faglia G
    J Clin Endocrinol Metab; 1985 Apr; 60(4):764-72. PubMed ID: 3919052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of bone morphogenetic protein-4 in GH regulation by octreotide and bromocriptine in rat pituitary GH3 cells.
    Miyoshi T; Otsuka F; Otani H; Inagaki K; Goto J; Yamashita M; Ogura T; Iwasaki Y; Makino H
    J Endocrinol; 2008 Apr; 197(1):159-69. PubMed ID: 18372242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine.
    Hiestand PC; Mekler P; Nordmann R; Grieder A; Permmongkol C
    Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2599-603. PubMed ID: 2939454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure, plasma and pituitary prolactin responses to bromocriptine in New Zealand genetically hypertensive and normotensive rats.
    Tan BK; Hutchinson JS
    Clin Exp Pharmacol Physiol; 1989 Jan; 16(1):13-8. PubMed ID: 2706805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of bromocriptine in patients with active rheumatoid arthritis].
    Figueroa F; Carrión F; Martínez ME; Rivero S; Mamani I; González G
    Rev Med Chil; 1998 Jan; 126(1):33-41. PubMed ID: 9629752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromocriptine Induces Autophagy-Dependent Cell Death in Pituitary Adenomas.
    Geng X; Ma L; Li Z; Li Z; Li J; Li M; Wang Q; Chen Z; Sun Q
    World Neurosurg; 2017 Apr; 100():407-416. PubMed ID: 28137551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
    Hess DA; Bird IA; Almawi WY; Rieder MJ
    J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of anti-interleukin-2 receptor antibody and cyclosporin A on human T cell proliferation in primary mixed lymphocyte reaction.
    Oiwa K; Sakagami K; Orita K
    Hiroshima J Med Sci; 1989 Mar; 38(1):1-6. PubMed ID: 2526799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of interleukin 2 in inducing Ig production in a pokeweed mitogen-stimulated mononuclear cell system.
    Nakagawa N; Nakagawa T; Volkman DJ; Ambrus JL; Fauci AS
    J Immunol; 1987 Feb; 138(3):795-801. PubMed ID: 3100616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.